Immunity against the omicron coronavirus variant fades rapidly after a second and third dose of Pfizer and BioNTech’s Covid-19 vaccine, according to peer reviewed research published in JAMA Network Open on Friday, a finding that could support rolling out additional booster shots to vulnerable people as the variant drives an uptick in new cases across the country.